Market Overview

Aimmune Therapeutics (NASDAQ: AIMT)

34.30 +0.01 (0.03%)

Analyst Ratings

DateResearch FirmActionCurrentPT
9/01/20Credit SuisseMaintainsNeutral34.5
9/01/20Cantor FitzgeraldDowngradesNeutral35.0
9/01/20WedbushDowngradesNeutral34.5
8/31/20Piper SandlerDowngradesNeutral34.5
7/29/20Credit SuisseMaintainsNeutral15.0
7/13/20Cowen & Co.Initiates Coverage OnOutperform35.0
5/13/20Credit SuisseMaintainsNeutral19.0
5/12/20StifelMaintainsHold20.0
5/12/20H.C. WainwrightReiteratesNeutral15.0
3/23/20Cantor FitzgeraldMaintainsOverweight32.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter